BCL6 and adenoma: Strikingly, our histological analysis showed that Kras activation with heterozygous or homozygous Bcl6 loss in lung epithelium was devoid of any hyperplasia or adenomas and even retained normal histology 12 weeks after Ad-Cre administration (Supplemental Figure 10).